AEON Biopharma, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2020 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
AEON Biopharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2020 to Q2 2024.
- AEON Biopharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $164M.
- AEON Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$52.6M, a 741% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)